Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español

NIDA Home > About NIDA > Organization   

Initial Review Group / Committee Structure
gray line


[IRG Meeting Dates for 2009 & 2010]



Office of Extramural Affairs Grant and Contract Review Committees
Code Committee Name
or Description
Scientific Review Administrator Research Areas
NIDA/K Training and
Career Development
Eliane Lazar-Wesley, Ph.D.
301-451-4530
elazarwe@nida.nih.gov
NIDA's remaining Institute-based standing review committee that reviews grant applications for career development and institutional training in research relevant to NIDA.
ZDA1-___- Special Emphasis
Panels (SEP)
Various NIDA SROs A NIDA Special Emphasis Panel (SEP) is recruited by the SRO for a special review, often a unique RFA or a Program Announcement (PA), for applications from standing review committee members or for contract proposals. Some recurring SEPsĘ reviewed at NIDA are listed below.
ZDA1-EXL-T Special Emphasis Panel (SEP) for NIDA Centers
http://www.nida.nih.gov/
funding/
grantguidelines_03.html
Eliane Lazar-Wesley, Ph.D.
301-451-4530
elazarwe@nida.nih.gov
Review complex multidisciplinary, multi-component applications with administrative and scientific cores and projects related to an integrating theme.
ZDA1-___- Special Emphasis
Panel (SEP) for
Program Projects (P01's) (various names depending upon topics)
http://www.nida.nih.gov/
funding/program_project
_guidelines.html
Various NIDA SROs Review complex multidisciplinary, multi-component applications with administrative and scientific cores and projects related to an integrating theme.
ZDA1-NXR-B Special Emphasis
Panel (SEP) for
Avant-Garde
http://grants.nih.gov/
grants/guide/rfa-files/
RFA-DA-08-003.html
Nadine Rogers, Ph.D.
301-402-2105
nadine.rogers@nih.gov
Review grant applications designed by individual scientists of exceptional creativity who propose approaches at the forefront of drug abuse and HIV/AIDS research.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
Conference Grants
http://grants.nih.gov/
grants/guide/pa-files/
PA-08-149.html
Gerald McLaughlin, Ph.D.
301-402-6626
gerald.mclaughlin@nih.gov
Review grant applications for high quality conferences/ scientific meetings relevant to NIDA's scientific and public health issues.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
B/START
http://grants.nih.gov/
grants/guide/pa-files/
PAR-09-239.html
Gerald McLaughlin, Ph.D.
301-402-6626
gerald.mclaughlin@nih.gov
Review grant applications to facilitate the entry of beginning investigators with behavioral science research relevant to drug abuse.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
I/START
http://grants.nih.gov/
grants/guide/pa-files/
PAR-06-311.html
Gerald McLaughlin, Ph.D.
301-402-6626
gerald.mclaughlin@nih.gov
Review grant applications to facilitate the entry of beginning investigators with brain imaging research relevant to drug abuse.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
CEBRA
http://grants.nih.gov/
grants/guide/pa-files/
PAR-06-209.html
Gerald McLaughlin, Ph.D.
301-402-6626
gerald.mclaughlin@nih.gov
Review grant applications to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them, and to support high-risk, potentially high-impact that is underrepresented or not included in NIDA's current portfolio.
*The standing review committees that reviewed the R mechanism, [NIDA/E (Treatment), NIDA/F (Health Services), and NIDA/L (Medication Development)], were dissolved in 2009, and most applications that would have been reviewed in these committees are now being reviewed in CSR.

Click here for rosters of review groups that are managed by the Center for Scientific Review or other Institutes.

For general committee information contact:

Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384.

For specific committee information contact the Scientific Review Officer listed above.

Office Address:

Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
6101 Executive Boulevard
Room 220, MSC 8401
Bethesda, Maryland 20892-8401

FAQ's for Grants and Contracts


About NIDA Contents




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, January 19, 2010. The U.S. government's official web portal